Vaccine Ontology
540 terms(s) returned
Term Type: | Record: 451 to 500 of 540 Records | Page: 10 of 11, First Previous Next Last | Show Records Per Page |
- recombinant Yersinia rV10 vaccine
- recombinant baculovirus encoding HA from Influenza A virus (A/Puerto Rico/8/1934(H1N1)) vaccine
- recombinant chimera BLSOmp31 vaccine
- recombinant hIFN-gamma/Interferon-g vaccine adjuvant
- recombinant heterologous vector vaccine
- recombinant homologous vector vaccine
- recombinant human Hsp110-gp100 chaperone complex vaccine
- recombinant nontypeable Haemophilus influenzae protein P6 vaccine with AdDP adjuvant
- recombinant protein vaccine preparation
- recombinant vaccine vector
- recombinant vaccine vector E. coli vaccine
- recombinant vaccine vector role
- recombinant vaccinia virus encoding HA from Influenza B virus (Strain B/England/222/82) vaccine
- recombinant vector vaccine
- recombinant vector vaccine preparation
- recombinant vector vaccine role
- recombinant vesicular stomatitis virus encoding HA from Influenza A virus (A/WSN/1933(H1N1)) vaccine
- recombinant viral vector vaccine
- record of missing knowledge
- record of unknown vaccine or immune globulin
- rectum cancer
- reduced virulence
- reduction of colony forming unit
- regulation-assigned role
- regulator role
- regulatory agency
- regulatory role
- relA from Mycobacterium avium
- relA from Salmonella Gallinarum
- relation
- relational quality
- relative correlate of immune protection
- renal cancer vaccine
- replicating adenovirus accine vector
- report
- reproductive organ cancer
- reproductive system disease
- requires discussion
- reserved cvx code for not using
- resiquimod vaccine adjuvant
- respiratory syncytial virus infectious disease
- respiratory syncytial virus monoclonal antibody (motavizumab) intramuscular
- respiratory syncytial virus monoclonal antibody (palivizumab) intramuscular
- respiratory system cancer
- respiratory system disease
- response to stimulus
- retrovector encoding mutant Anti-Cyclin G1 vaccine
- retroviral vaccine vector
- review of vaccine license application
- rfaF from Neisseria meningitidis